Deal supported by Xplico

By |November, 2014|

Lexicon And Ipsen Enter Into Ex-North America/Japan Licensing And Commercialization Agreement For Telotristat Etiprate

Deal supported by Xplico

By |November, 2014|

Dicerna Announces License Agreement with Tekmira to Advance Dicerna’s PH1 Development Program

Deal supported by Xplico

By |November, 2014|

LEO Pharma and Japan Tobacco Enter into License Agreement for Novel JAK inhibitor Drug Candidate

Deal supported by Xplico

By |October, 2014|

Bavarian Nordic Enters Licensing and Supply Agreement with Janssen on MVA-BN® Ebola Vaccine

Bio International Convention, Philadelphia, USA, June 3-6, 2019

By |September, 2014|

Bio International Convention, Philadelphia, USA, June 3-6, 2019

Please meet us at the BIO International Convention in Philadelphia in June 2019. The key benefits of attending the Convention are access to global biotech and pharma leaders via BIO One-on-One Partnering, exposure to industry though-leaders and unparalleled networking opportunities with 16,000+ attendees from 74 countries.

Deal supported by Xplico

By |September, 2014|

Distribution, License & Supply Agreement Announced with Medical Developments International

Deal supported by Xplico

By |August, 2014|

Allergan Acquires LiRIS®Program from TARIS Biomedical®

Deal supported by Xplico

By |August, 2014|

uniQure Acquires Cardiology Gene Therapy Company InoCard

Deal supported by Xplico

By |August, 2014|

Medivir licenses Respiratory Syncytial Virus drug program from Boehringer Ingelheim

Deal supported by Xplico

By |July, 2014|

Zealand and Boehringer Ingelheim sign second collaboration agreement to advance novel peptide medicines

Deal supported by Xplico

By |July, 2014|

LEO Pharma & KLOX Technologies strike global dermatology deal

Deal supported by Xplico

By |July, 2014|

PharmaMar and Chugai Pharma Marketing Enter into a License and Commercialization Agreement in Europe for Aplidin®

Deal supported by Xplico

By |July, 2014|

PharmaMar signs licence agreement with GP Pharm to market Politrate® in Italy for treating prostate cancer

Deal supported by Xplico

By |June, 2014|

Immunocore and Lilly Enter Immunotherapy Agreement to Co-Discover and Co-Develop Novel Cancer Therapies

Deal supported by Xplico

By |March, 2014|

Santen and TRACON Announce Agreement for the Development and Commercialization of TRC105 in Ophthalmology

Deal supported by Xplico

By |February, 2014|

Verastem Acquires Rights to Cancer Stem Cell Inhibitor VS-4718